These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20551888)

  • 1. Hormone-based contraceptive therapy and risk of venous thromboembolism in young women.
    Roberts H
    Clin Adv Hematol Oncol; 2010 May; 8(5):307-9. PubMed ID: 20551888
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 4. [Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2004 Jun; 124(11):1521-2. PubMed ID: 15195157
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".
    Heinemann LA; Dinger JC; Assmann A; Minh TD
    Contraception; 2010 May; 81(5):401-7. PubMed ID: 20399946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scare over oral contraceptives. Studies implicate only gestodene and desogestrel.
    Donnelly RJ
    BMJ; 1995 Dec; 311(7020):1639. PubMed ID: 8555821
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives and insulin sensitivity.
    Cagnacci A
    Fertil Steril; 2006 Aug; 86(2):495-6; author reply 496-7. PubMed ID: 16892490
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptives and venous thromboembolism.
    Speroff L
    Int J Gynaecol Obstet; 1996 Jul; 54(1):45-50. PubMed ID: 8842817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
    Dinger J; Shapiro S
    J Fam Plann Reprod Health Care; 2012 Jan; 38(1):2-6. PubMed ID: 22128104
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of blood clots higher for oral contraceptives with certain progestins.
    Voelker R
    JAMA; 2011 Nov; 306(20):2206. PubMed ID: 22110099
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancies and terminations after 1995 warning about third-generation oral contraceptives.
    Jick SS; Vasilakis C; Jick H
    Lancet; 1998 May; 351(9113):1404-5. PubMed ID: 9593415
    [No Abstract]   [Full Text] [Related]  

  • 13. Third generation oral contraceptives--the controversy.
    Carnall D; Karcher H; Lie LG; Sheldon T; Spurgeon D; Josefson D; Zinn C
    BMJ; 1995 Dec; 311(7020):1589-90. PubMed ID: 8555796
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of oral contraceptives and cardiovascular disease.
    Vandenbroucke JP; Helmerhorst FM; Rosendaal FR
    Ann Intern Med; 1998 Nov; 129(9):747. PubMed ID: 9841612
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
    Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
    Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract]   [Full Text] [Related]  

  • 17. Third generation oral contraceptives.
    Skegg DC
    BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631
    [No Abstract]   [Full Text] [Related]  

  • 18. No alert from CPMP on oral contraceptives.
    Lancet; 1996 Apr; 347(9009):1175. PubMed ID: 8609762
    [No Abstract]   [Full Text] [Related]  

  • 19. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral venous thrombosis as a complication of oral contraceptive use in a 15-year-old patient: a case report.
    Hill LW; Hindelang FM
    J La State Med Soc; 2007; 159(4):195, 197. PubMed ID: 17987956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.